Worcester, University of Massachusetts, MA, USA - 25 Sep `20Study to Evaluate RECELL and MKTP for Repigmentation of Stable Vitiligo Lesions


Official Title: Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

In Brief: Prospective randomized within-subject controlled feasibility study to evaluate the clinical performance of RECELL for repigmentation of stable, depigmented lesions. The trial will evaluate 50 matched, stable depigmented areas from 10 subjects.

Ages Eligible: 22 Years and older 

Start Date: September 25, 2020

Completion Date (estimated): December 2021

Status: Recruiting

Study ID from ClinicalTrials.gov: NCT04271501
Other Study ID Numbers: CTP008


  • Worcester, University of Massachusetts, MA, USA. Contact: Celia Hartigan at Celia.Hartigan@umassmed.edu    

Contact: To learn more about this study, you or your doctor may contact 

Elizabeth Kirshner
Lisa Carothers

Please refer to this study by its NCT number.

FAQOther Questions

  • Can chemicals cause vitiligo?

    It’s important to remember there are multiple factors involved in vitiligo onset, including genetic predisposition, living and working environments, and exposure to certain chem...

  • Vitiligo and hearing loss: any connection?

    In short, NO. Recent research shows no relationship between a degree of skin depigmentation and hearing loss severity in vitiligo patients. The results of this study showed tha...

  • Can Ayurveda help with vitiligo?

    People have used herbs and natural remedies to treat skin conditions for centuries. Vitiligo is an auto-immune condition that causes white patches of skin to develop and expand...